Zobrazeno 1 - 10
of 62 636
pro vyhledávání: '"diphtheria"'
Autor:
Suwaid SA; Department of Pediatrics, Diphtheria Treatment Center, Murtala Muhammad Specialist Hospital (MMSH), Kano, Nigeria.; Hospital Management Board (HMB), Kano, Nigeria., Mustapha A; Vanke School of Public Health, Tsinghua University, Beijing, China. mustaphaaliyu88@yahoo.com., Ried M; Klinikum München Bogenhausen, Munich, Germany., Muhammad RA; Ahmadu Bello University, Zaria, Nigeria., Liman AS; Department of Pediatrics, Diphtheria Treatment Center, Murtala Muhammad Specialist Hospital (MMSH), Kano, Nigeria.; Ahmadu Bello University, Zaria, Nigeria., Yusuf S; Department of Pediatrics, Diphtheria Treatment Center, Murtala Muhammad Specialist Hospital (MMSH), Kano, Nigeria.
Publikováno v:
Journal of medical case reports [J Med Case Rep] 2024 Sep 06; Vol. 18 (1), pp. 433. Date of Electronic Publication: 2024 Sep 06.
Autor:
Richmond P; University of Western Australia School of Medicine, Department of Immunology, Perth Children's Hospital and Telethon Kids Institute, Nedlands, WA, Australia., Nolan T; Vaccine and Immunisation Research Group (VIRGo), Peter Doherty Institute for Infection and Immunity at the University of Melbourne and Murdoch Children's Research Institute, Melbourne, VIC, Australia., McGirr A; Northern Beaches Clinical Research, Brookvale, NSW, Australia., Napier-Flood F; Paratus Clinical Research Western Sydney, Blacktown, NSW, Australia., Kim J; Paratus Clinical Research Central Coast, Kanwal, NSW, Australia., Leah A; Paratus Clinical Research Canberra, Bruce, ACT, Australia., Xie F; Dynavax Technologies Corporation, Emeryville, CA, USA., Campbell JD; Dynavax Technologies Corporation, Emeryville, CA, USA., Godeaux O; ZAM Consulting, Brussels, Belgium., Henry O; Dynavax Technologies Corporation, Emeryville, CA, USA., Wood N; Kids Research, The Children's Hospital at Westmead, Westmead, NSW, Australia., Janssen RS; Dynavax Technologies Corporation, Emeryville, CA, USA. Electronic address: rjanssen@dynavax.com.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126251. Date of Electronic Publication: 2024 Sep 02.
Autor:
Wanlapakorn N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Sarawanangkoor N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Srimuan D; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thatsanathorn T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thongmee T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2352909. Date of Electronic Publication: 2024 May 16.
Autor:
Elenge DM; GSK, Wavre, Belgium., Heo JS; Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea., Kim SS; Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea., Kim YK; Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea., Lee JH; Department of Pediatrics, Ajou University School of Medicine, Suwon, South Korea., Xavier S; GSK, Bangalore, India., Bahar E; GSK, Wavre, Belgium., Dos Santos G; GSK, Wavre, Belgium., Guignard A; GSK, Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2406060. Date of Electronic Publication: 2024 Oct 08.
Autor:
Zhu Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Sun L; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang J; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Li J; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang L; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Guo Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2372884. Date of Electronic Publication: 2024 Jul 03.
Autor:
Guerra A; Research, MSD (UK) Limited, London, UK., Costantino C; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Excellence Specialties, University of Palermo, Palermo, Italy., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; GENVIP Research Group (www.genvip.eu), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Westerholt S; Pediatrics, Praxis für Kinder- und Jugendmedizin, Wolfsburg, Germany., Lambeth C; Research, Merck & Co., Inc., Rahway, USA., Chen Z; Research, Merck & Co., Inc., Rahway, USA., Lumley J; Research, Merck & Co., Inc., Rahway, USA., Marcek T; Vaccine, MCM Vaccine B.V, Leiden, Netherlands., Johnson D; Vaccine, Sanofi Vaccines, Swiftwater, USA., Wilck M; Research, Merck & Co., Inc., Rahway, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2310900. Date of Electronic Publication: 2024 Feb 08.
Autor:
Hendry AJ; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW., Quinn HE; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW., Macartney K; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW., Beard FH; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW.
Publikováno v:
The Medical journal of Australia [Med J Aust] 2024 Aug 19; Vol. 221 (4), pp. 224-225. Date of Electronic Publication: 2024 Jul 17.
Autor:
Tanaka M; Department of Health Care Policy and Management, Doctoral Program in Public Health, Degree Programs in Comprehensive Human Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 3058577, Japan. Electronic address: s2130443@u.tsukuba.ac.jp., Okubo R; Department of Health Care Policy and Health Economics, Institute of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 3058577, Japan; Department of Clinical Laboratory Medicine, University of Tsukuba Hospital, 2-1-1, Amakubo, Tsukuba, Ibaraki 3058576, Japan., Hoshi SL; Department of Health Care Policy and Health Economics, Institute of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 3058577, Japan., Kondo M; Department of Health Care Policy and Health Economics, Institute of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 3058577, Japan.
Publikováno v:
Vaccine [Vaccine] 2024 Mar 19; Vol. 42 (8), pp. 2081-2088. Date of Electronic Publication: 2024 Feb 27.
Autor:
Nakano T; Professor, Department of Pediatrics, Kawasaki Medical School, Japan., Hasegawa M; Mitsubishi Tanabe Pharma Corporation, Japan., Endo M; Mitsubishi Tanabe Pharma Corporation, Japan., Matsuda K; Clinical Development Department, Clinical Development Section, The Research Foundation for Microbial Diseases of Osaka University, Japan. Electronic address: clinicaldevelopment@mail.biken.or.jp., Tamai H; Clinical Development Department, Clinical Development Section, The Research Foundation for Microbial Diseases of Osaka University, Japan.
Publikováno v:
Vaccine [Vaccine] 2024 Apr 30; Vol. 42 (12), pp. 3134-3143. Date of Electronic Publication: 2024 Apr 06.
Autor:
Simonetti O; Infectious Diseases Unit, University Hospital of Trieste, Italy., Cosimi L; Infectious Diseases Unit, University Hospital of Trieste, Italy., Cigana M; Emergency Department, San Jacopo Hospital, Pistoia, Italy., Penco A; Department of Pediatrics, Latisana-Palmanova Hospital, ASUFC, Udine, Italy., DI Bella S; Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy., Martini M
Publikováno v:
Journal of preventive medicine and hygiene [J Prev Med Hyg] 2024 Mar 31; Vol. 65 (1), pp. E98-E104. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024).